Dallas Pharmaceutical Corp is categorized under Wholesale Pharmaceutical Products in Richardson, TX and active since 2011.
Dallas Pharmaceutical Corp was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Nedal Naser at the company’s single location by writing to 310 East Main St # 103, Richardson, Texas TX 75081 or by phoning (972) 992-8205. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Dallas Pharmaceutical Corp |
Contact Person: | Nedal Naser |
Address: | 310 East Main St # 103, Richardson, Texas 75081 |
Phone Number: | (972) 992-8205 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Dallas Pharmaceutical Corp was started in 2011 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Nedal Naser for inquiries that concern Dallas Pharmaceutical Corp by calling the company number (972) 992-8205, as your correspondence is most welcome. Additionally, the physical location of the single location of Dallas Pharmaceutical Corp can be found at the coordinates 32.948182,-96.72897 as well as the street address 310 East Main St # 103 in Richardson, Texas 75081.
For its online presence, you may visit Dallas Pharmaceutical Corp’s website at and engage with its social media outlets through on Twitter and on Facebook.